Cafepharma Today

September 25 2018 - AZ’s Imfinzi provides unprecedented progression-free survival in NSCLC
AZ’s Imfinzi provides unprecedented progression-free survival in NSCLC
Express Scripts takes credit for Gilead hep C generics
Novartis cutting 2000 jobs in Switzerland
Arena’s Crohn’s drug meets proof-of-concept test
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

submit a press release
Ionis, Rockefeller team find peripheral blood target for Alzheimer's
BioCentury
Tuesday, September 25, 2018 - 7:47pm
tags:
Ionis Pharmaceuticals, Rockefeller University, Alzheimer's disease, drug development
Dance Biopharm raises $24m for inhaled insulin device
Drug Delivery Business News
Tuesday, September 25, 2018 - 7:34pm
tags:
Dance Biopharm, inhaled insulin, diabetes
AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more
Fierce Pharma
Tuesday, September 25, 2018 - 7:19pm
tags:
AbbVie, Biogen, Sanofi, Gilead Sciences
Abbott touts low rates of stroke, death in 1-year Portico TAVR study
Mass Device
Tuesday, September 25, 2018 - 7:15pm
tags:
Abbott Labs, devices, Portico Transcatheter Aortic Heart Valve
Tax Reform No Shot In Arm For Pharma Deals
Forbes
Tuesday, September 25, 2018 - 7:07pm
tags:
M&A, tax reform, taxes
New Patent Database to Help Governments Procure Medicines
RAPS.org
Tuesday, September 25, 2018 - 7:06pm
tags:
patents
Morphic Nets Another $80M For Integrin Drugs & First Human Tests
Xconomy
Tuesday, September 25, 2018 - 7:04pm
tags:
Morphic Therapeutic, integrin drugs
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
CP Wire
Tuesday, September 25, 2018 - 11:50am
tags:
AstraZeneca, MedImmune, Imfinzi, non-small cell lung cancer
Express Scripts praises, then takes credit for Gilead's authorized generics launches
Fierce Pharma
Tuesday, September 25, 2018 - 11:47am
tags:
Gilead Sciences, Express Scripts, generics, hepatitis C
Catabasis Pharmaceuticals Initiates Ph III Trial for Promising Duchenne Muscular Dystrophy Drug
CP Wire
Tuesday, September 25, 2018 - 11:41am
tags:
Catabasis, edasalonexent, Duchenne Muscular Dystrophy
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
Fierce Biotech
Tuesday, September 25, 2018 - 10:01am
tags:
Arena Pharmaceuticals, olorinab, Crohn's Disease
TG stock sinks after setback to blood cancer trial
Fierce Biotech
Tuesday, September 25, 2018 - 9:59am
tags:
TG Therapeutics, FDA, ublituximab-umbralisib, CLL, chronic lymphocytic leukemia

Pages

Latest CP Wire Articles

Catabasis Pharmaceuticals Initiates Ph III Trial for Promising Duchenne Muscular Dystrophy Drug
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
Ex-Novartis Chief Joins uBiome to Help Launch Discovery and Development Business
MicuRx Recieves Fast Track and QIDP Designations for MRSA Antiobiotics
Microbiome Report for Week Ending 9/15/18

Latest Pharmagather Articles

Why Your Advertising Agency Should Be Your Analytics Partner
pharmexec marketing
Why It s Time to Get Smarter about Content Management and Document Production
pharmexec r&d
Why It s Time to Get Smarter about Content Management and Document Production
pharmexec technology
Why Your Advertising Agency Should Be Your Analytics Partner
pharmexec technology
Vaccines Against a Vanishing Virus?
In the Pipeline
The Cigna-Express Scripts Deal's Intriguing Connections With—And Implications For—AmerisourceBergen and Walgreens
Drug Channels
Versatile Optimization, While You Wait
In the Pipeline
Digital Health: "It's Not About the App"
pharmexec technology
CBI’s 10th Federal Pricing and Reporting – VA, DoD, PHS
Drug Channels
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Onconova Therapeutics Announces Reverse Stock Split
Tuesday, September 25, 2018 - 9:16am
Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Tuesday, September 25, 2018 - 8:00am
Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
Tuesday, September 25, 2018 - 7:00am
BriaCell Therapeutics Corp. Discusses its Plan to Revolutionize Cancer Immunotherapy in Exclusive NetworkNewsWire Audio Interview
Tuesday, September 25, 2018 - 6:30am
Morten Marott Steps Down as Chief Financial Officer of Veloxis Pharmaceuticals A/S
Monday, September 24, 2018 - 1:53pm
Axiom Real-Time Metrics Set to Attend the 2018 MedTech Conference in Philadelphia
Monday, September 24, 2018 - 12:17pm
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at the Society for Clinical Data Management (SCDM) 2018 Annual Conference
Monday, September 24, 2018 - 12:14pm
Radius Health to Present Data on Abaloparatide at ASBMR 2018 Annual Meeting
Monday, September 24, 2018 - 8:00am
Axsome Therapeutics to Present at Upcoming Investor Conferences
Monday, September 24, 2018 - 7:00am
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
Monday, September 24, 2018 - 7:00am

Breaking Healthcare News - powered by Seeking Alpha

Opiant prices stock offering at $17; shares down 19% premarket
Tuesday, September 25, 2018 - 9:28am
Quest Diagnostics to acquire U.S. lab operations of Oxford Immunotec
Tuesday, September 25, 2018 - 9:25am
Aldeyra's ganetespib shows positive effect in mesothelioma study; shares ahead 5% premarket
Tuesday, September 25, 2018 - 9:17am
VBI Vaccines' study of VBI-1901 in GBM to continue as planned; shares ahead 11% premarket
Tuesday, September 25, 2018 - 8:56am
Neogen beats by $0.01, misses on revenue
Tuesday, September 25, 2018 - 8:54am
MiMedx up 6% premarket on positive data on dHUC in diabetic foot ulcers
Tuesday, September 25, 2018 - 8:46am
Premarket analyst action - healthcare
Tuesday, September 25, 2018 - 8:31am
Vivos to halt the toxic selling and eliminate the secured toxic debt
Monday, September 24, 2018 - 9:21am
AzurRx Bio's MS1819-SD successful in mid-stage EPI study; shares ahead 26% premarket
Monday, September 24, 2018 - 9:11am
Verrica Pharmaceuticals to join Russell indexes
Monday, September 24, 2018 - 9:09am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.